文献速递血液透析通路

COVID-19患者临时血液透析导管功能障碍的预防措施研究

Malfunctioning temporary hemodialysis catheters in patients with novel coronavirus disease 2019.
PubMed 文献 · J Vasc Surg · 2020-12-05

该回顾性研究分析了48例COVID-19阳性并放置临时血液透析导管(THDC)的患者,评估肝素封管、增加静脉血栓栓塞(VTE)预防剂量及全身抗凝与导管通畅性的关联。

要点

  • 肝素封管与COVID-19患者THDC功能障碍风险降低显著相关。
  • 皮下肝素7500U每日三次可能改善THDC通畅性,但证据有限。
  • D-二聚体升高与死亡率增加相关,但与THDC功能障碍无显著关联。

核心结论

  • 肝素封管与COVID-19患者临时血液透析导管功能障碍率降低相关。
  • 增加VTE预防剂量可能改善导管通畅性,但统计效能不足。
  • 全身抗凝未显著影响THDC功能障碍率。

研究设计与样本

  • 回顾性病历审查,纳入2020年2月1日至4月30日COVID-19阳性且需放置THDC的患者48例。
  • 采用比例风险模型进行生存分析,评估三种预防措施与THDC功能障碍的关系。

主要发现

  • 48例患者死亡率为71%,THDC功能障碍发生率为31.3%。

临床怎么用

  • 对于COVID-19患者放置THDC,可考虑肝素封管以降低功能障碍风险。
  • 增加VTE预防剂量可能有益,但需更多证据支持。

局限性

  • 回顾性研究设计,样本量小(48例)。
  • 部分比较统计效能不足。
  • 需要前瞻性随机研究确认 findings。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The hypercoagulability seen in patients with novel coronavirus disease 2019 (COVID-19) likely contributes to the high temporary hemodialysis catheter (THDC) malfunction rate. We aim to evaluate prophylactic measures and their association with THDC patency. METHODS: A retrospective chart review of our institutions COVID-19 positive patients who required placement of a THDC between February 1 to April 30, 2020, was performed. The association between heparin locking, increased dosing of venous thromboembolism (VTE) prophylaxis and systemic anticoagulation on THDC patency was assessed. Proportional hazards modeling was used to perform a survival analysis to estimate the likelihood and timing of THDC malfunction with the three different prophylactic measures. We also determined the mortality, rate of THDC malfunction and its association with d-dimer levels. RESULTS: A total of 48 patients with a mortality rate of 71% were identified. THDC malfunction occurred in 31.3% of patients. Thirty-seven patients (77.1%) received heparin locking, 22 (45.8%) received systemic anticoagulation, and 38 (79.1%) received VTE prophylaxis. Overall, the rate of THDC malfunction was lower at a trend level of significance, with heparin vs saline locking (24.3% vs 54.6%; P = .058). The likelihood of THDC malfunction in the heparin locked group is lower than all other groups (hazard ratio [HR], 0.07; 95% confidence interval [CI], 0.01-0.45]; P = .005). The rate of malfunction in patients with subcutaneous heparin (SQH) 7500 U three times daily is significantly lower than of the rate for patients receiving none (HR, 0.03; 95% CI, 0.001-0.74; P = .032). A trend level significant association was found for SQH 5000 U vs none (P = .417) and SQH 7500 vs 5000 U (P = .059). Systemic anticoagulation did not affect the THDC malfunction rate (P = .240). Higher d-dimer levels were related to greater mortality (HR, 3.28; 95% CI, 1.16-9.28; P = .025), but were not significantly associated with THDC malfunction (HR, 1.79; 95% CI, 0.42, 7.71; P = .434). CONCLUSIONS: Locking THDCs with heparin is associated with a lower malfunction rate. Prospective randomized studies will be needed to confirm these findings to recommend locking THDC with heparin in patients with COVID-19. Increased VTE prophylaxis suggested a possible association with improved THDC patency, although the comparison lacked sufficient statistical power.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kanitra JJ, Power AD, Hayward RD, et al. Malfunctioning temporary hemodialysis catheters in patients with novel coronavirus disease 2019. J Vasc Surg. 2020. PMID: 33290813. doi:10.1016/j.jvs.2020.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。